Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cabozantinib
Psoriatic Arthritis
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Rheumatoid Arthritis
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Sjogren Syndrome
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Renal Pelvis/Ureter Urothelial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Ureter Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Systemic Lupus Erythematosus
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Systemic Sclerosis
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Ulcerative Colitis
National Cancer Institute (NCI)
P1
CC
(43)
Carboplatin
Liver Failure
National Cancer Institute (NCI)
P1
CC
(43)
Carboplatin
Testicular Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Carboplatin
Kidney Failure
National Cancer Institute (NCI)
P1
CC
(43)
Cedazuridine
Breast Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cedazuridine
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Cedazuridine
Hodgkins Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Colon Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Gastric Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Salivary Gland Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Gastric Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
HER2 Positive Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Hepatobiliary Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Colon Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Colorectal Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Major Salivary Gland Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Uterine Corpus Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2751 to 2775 of 3,272 assets
Previous
Page 111 of 131
Next